Follow the 메디톡스 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 메디톡스 has recorded 80 public disclosures. Market capitalisation: €468bn. The latest transaction was filed on 2 April 2026 (Purchase). Among the most active insiders: 정현호. Every trade is free.
78
Insider Decl.
n/a
Thresholds
n/a
37 ops.
Buy Volume
n/a
3 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 14,394 of 28,832 companies
52.0
score / 100
Value
51
Quality
53
FCF yld6.2%
Earn yld3.8%
EV/EBITDA18.9x
ROE3.6%
Gross mgn58%
Net mgn6.7%
Debt/EBITDA2.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Medytox is a company specializing in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on the development of biopharmaceutical products.